My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Genmab



Genmab A/S
Public (OMX: GEN)
Founded1999
HeadquartersCopenhagen, Denmark
Key peopleLisa Drakeman (President and CEO)
Michael Widmer (Chairman of the board)
IndustryBiotechnology
ProductsPharmaceuticals, antibodies
RevenueDKK 135.5 million (2006)[1]
Profit DKK 438.2 million (2006)[1]
Employees237 (2006)[1]
Websitewww.genmab.com

Genmab A/S (OMX: GEN) is a Danish pharmaceutical company, founded in February 1999 and based in Copenhagen. Internationally, it operates through the subsidiaries Genmab BV in Utrecht, The Netherlands, Genmab Ltd in Hertfordshire, United Kingdom and Genmab, Inc in Princeton, New Jersey, USA, and is publicly traded on the OMX Nordic Exchange and the OMX Copenhagen 20.[2]

Research Pipeline

Status of major offerings in Genmab's research pipeline, as of late 2007.[3]

Name Indications Status Collaborations
HuMax-CD4
(zanolimumab) 		Cutaneous T Cell lymphoma (CTCL) Phase III
Non-cutaneous T Cell lymphoma (NCTCL) Phase II (completed)
HuMax-CD20
(ofatumumab) 		Chronic lymphocytic leukemia (CLL) Phase III GSK
Non-Hodgkin’s lymphoma (NHL) Phase III
Rheumatoid Arthritis (RA) Phase III
Diffuse large B cell lymphoma (DLBCL) Phase II
HuMax-EGFr
(zalutumumab) 		Head and neck cancer Phase III n/a
Non small cell lung cancer Phase II n/a
HuMax-IL15
(AMG 714) 		Rheumatoid Arthritis (RA) Phase II (completed) Amgen
Psoriasis Phase I
HuMax-IL8 Palmoplantar pustulosis Phase I/II (completed)
HuMax-CD38 Multiple myeloma Phase I/II
R1507 Cancer Phase I (completed) Roche
Roche 2 undisclosed Phase I Roche
Roche 3 undisclosed Phase I Roche
Roche 4 Asthma Phase I Roche
HuMax-HepC Hepatitis C pre-clinical Connex GmbH and INSERM
HuMax-TAC Organ transplant rejection Pre-clinical

References

  1. ^ a b c Annual Report 2006. Genmab A/S (29 March, 2007). Retrieved on 2007-12-19.
  2. ^ Company Profile from the Genmab website
  3. ^ http://www.genmab.com/ScienceAndResearch/ProductsinDevelopment.aspx
v • d • e
OMX Copenhagen 20 companies of Denmark

A.P. Møller-Mærsk · Carlsberg · D/S Norden · Danisco · Danske Bank · DSV · FLSmidth & Co. · GN Store Nord · Genmab · Lundbeck · NKT Holding · Nordea · Novo Nordisk · Novozymes · Sydbank · Topdanmark · TrygVesta · Vestas Wind Systems · William Demant


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Genmab". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE